Ignite Creation Date:
2025-12-24 @ 12:34 PM
Ignite Modification Date:
2026-02-28 @ 11:21 AM
Study NCT ID:
NCT00865761
Status:
COMPLETED
Last Update Posted:
2010-08-17
First Post:
2009-03-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Relative Bioavailability Study of Alprazolam 3 mg ER Tablets Under Fasting Conditions
Sponsor:
Actavis Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
R05-0851
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Meena Venugopal, Director, Clinical R&D
Old Organization:
Actavis Inc